2015 Dec;5(6s):31-37.
Abstract
Individuals with multiple sclerosis (MS) spasticity present a wide range of symptoms and disability levels that are frequently challenging to manage. At the MS Experts Summit 2015, five country breakout sessions were conducted in parallel, and mainly in the native language, to examine various aspects about the management of treatment-resistant MS spasticity. Topics covered included video documentation of MS spasticity management (Germany), use of cannabinoid medicines in daily practice (Italy), multidisciplinary approach to MS spasticity care (France), titration and adherence to treatments for MS spasticity (Spain) and management of MS symptoms (Norway/Rest of World). For the benefit of all attendees, session highlights were collated and presented in a Plenary Session which is summarized herein.
KEYWORDS:
THC:CBD oromucosal spray; gait disturbances; goals of therapy; multidisciplinary teams; multiple sclerosis; spasticity; symptom management
- PMID:
- 26611270
- [PubMed – as supplied by publisher]